Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation.

Charlene Smith-Geater, Sarah J Hernandez, Ryan G Lim, Miriam Adam, Jie Wu, Jennifer T Stocksdale, Brook T Wassie, Maxwell Philip Gold, Keona Q Wang, Ricardo Miramontes, Lexi Kopan, Iliana Orellana, Shona Joy, Paul J Kemp, Nicholas D Allen, Ernest Fraenkel, Leslie M Thompson
Author Information
  1. Charlene Smith-Geater: Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA 92697, USA.
  2. Sarah J Hernandez: Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA.
  3. Ryan G Lim: Department of Memory Impairment and Neurological Disorders, University of California Irvine, Irvine, CA 92697, USA.
  4. Miriam Adam: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  5. Jie Wu: Department of Biological Chemistry, University of California Irvine, Irvine, CA 92617, USA.
  6. Jennifer T Stocksdale: Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA.
  7. Brook T Wassie: LeadCrunch, San Diego, CA 92101, USA.
  8. Maxwell Philip Gold: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  9. Keona Q Wang: Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA.
  10. Ricardo Miramontes: Department of Memory Impairment and Neurological Disorders, University of California Irvine, Irvine, CA 92697, USA.
  11. Lexi Kopan: Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA.
  12. Iliana Orellana: Department of Memory Impairment and Neurological Disorders, University of California Irvine, Irvine, CA 92697, USA.
  13. Shona Joy: Neural Stem Cell Institute, Rensselaer, NY 12144, USA.
  14. Paul J Kemp: School of Biosciences, Cardiff University, Cardiff CF10 3AX, UK.
  15. Nicholas D Allen: School of Biosciences, Cardiff University, Cardiff CF10 3AX, UK.
  16. Ernest Fraenkel: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  17. Leslie M Thompson: Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA 92697, USA; Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA 96267, USA; Department of Memory Impairment and Neurological Disorders, University of California Irvine, Irvine, CA 92697, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA; Department of Biological Chemistry, University of California Irvine, Irvine, CA 92617, USA. Electronic address: lmthomps@uci.edu.

Abstract

Aberrant neuronal development and the persistence of mitotic cellular populations have been implicated in a multitude of neurological disorders, including Huntington's disease (HD). However, the mechanism underlying this potential pathology remains unclear. We used a modified protocol to differentiate induced pluripotent stem cells (iPSCs) from HD patients and unaffected controls into neuronal cultures enriched for medium spiny neurons, the cell type most affected in HD. We performed single-cell and bulk transcriptomic and epigenomic analyses and demonstrated that a persistent cyclin D1 neural stem cell (NSC) population is observed selectively in adult-onset HD iPSCs during differentiation. Treatment with a WNT inhibitor abrogates this NSC population while preserving neurons. Taken together, our findings identify a mechanism that may promote aberrant neurodevelopment and adult neurogenesis in adult-onset HD striatal neurons with the potential for therapeutic compensation.

Keywords

References

  1. Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14610-5 [PMID: 23898200]
  2. Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3585-90 [PMID: 17360686]
  3. Cell Signal. 2017 Feb;31:1-14 [PMID: 27988204]
  4. Hum Mol Genet. 2015 Jun 1;24(11):3257-71 [PMID: 25740845]
  5. Nat Neurosci. 2017 May;20(5):648-660 [PMID: 28319609]
  6. Neuroreport. 2004 Apr 9;15(5):811-3 [PMID: 15073520]
  7. Development. 2013 Jan 15;140(2):301-12 [PMID: 23250204]
  8. Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E762-E771 [PMID: 29311338]
  9. Stem Cells. 2005 Apr;23(4):489-95 [PMID: 15790770]
  10. Development. 2018 Jan 29;145(2): [PMID: 29378824]
  11. Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12682-7 [PMID: 15314234]
  12. J Neurosci. 2005 Dec 14;25(50):11564-76 [PMID: 16354914]
  13. Cell Rep. 2019 Feb 26;26(9):2494-2508.e7 [PMID: 30811996]
  14. BMC Med Genomics. 2019 Oct 16;12(1):137 [PMID: 31619230]
  15. Am J Physiol Cell Physiol. 2016 Apr 1;310(7):C520-41 [PMID: 26718628]
  16. Exp Cell Res. 2005 Feb 1;303(1):32-46 [PMID: 15572025]
  17. Stem Cell Res Ther. 2015 Jun 16;6:120 [PMID: 26076648]
  18. Cell Stem Cell. 2012 Aug 3;11(2):264-78 [PMID: 22748968]
  19. Hum Mol Genet. 2015 Mar 15;24(6):1602-16 [PMID: 25398943]
  20. BMC Bioinformatics. 2009 Feb 03;10:48 [PMID: 19192299]
  21. J Huntingtons Dis. 2019;8(2):171-179 [PMID: 31045518]
  22. Nature. 2012 Jan 04;481(7381):389-93 [PMID: 22217937]
  23. Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16707-12 [PMID: 18922775]
  24. J Neurosci. 2008 Jan 16;28(3):622-32 [PMID: 18199763]
  25. Mol Cell Neurosci. 2004 May;26(1):135-43 [PMID: 15121185]
  26. PLoS Comput Biol. 2007 Mar 23;3(3):e39 [PMID: 17381235]
  27. Neuroscience. 2004;127(2):319-32 [PMID: 15262322]
  28. Nucleic Acids Res. 2013 Jan;41(Database issue):D377-86 [PMID: 23193289]
  29. Arq Neuropsiquiatr. 2006 Mar;64(1):5-9 [PMID: 16622544]
  30. Stem Cell Rev Rep. 2013 Aug;9(4):461-74 [PMID: 23625190]
  31. Nat Neurosci. 2012 May;15(5):713-21 [PMID: 22466506]
  32. J Clin Invest. 2013 Dec;123(12):5371-88 [PMID: 24231356]
  33. EMBO J. 2010 Jul 21;29(14):2433-45 [PMID: 20531388]
  34. Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21900-5 [PMID: 19955426]
  35. Mol Neurobiol. 2018 Apr;55(4):3351-3371 [PMID: 28497201]
  36. Stem Cell Reports. 2015 Dec 8;5(6):1023-1038 [PMID: 26651603]
  37. Neuroscience. 2005;132(3):777-88 [PMID: 15837138]
  38. J Huntingtons Dis. 2019;8(3):257-269 [PMID: 31381521]
  39. Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9023-7 [PMID: 12853570]
  40. PLoS One. 2011;6(11):e27231 [PMID: 22076139]
  41. Cell. 1993 Mar 26;72(6):971-83 [PMID: 8458085]
  42. J Cell Sci. 2013 Mar 1;126(Pt 5):1278-86 [PMID: 23345405]
  43. Mol Neurobiol. 2015 Feb;51(1):406-23 [PMID: 24788684]
  44. Cell Rep. 2017 May 16;19(7):1365-1377 [PMID: 28514657]
  45. Acta Neuropathol. 2017 Jun;133(6):907-922 [PMID: 28357566]
  46. Neurobiol Dis. 2010 Jul;39(1):28-39 [PMID: 20170730]
  47. Neuron. 2019 Mar 6;101(5):801-819 [PMID: 30844400]
  48. N Biotechnol. 2017 Oct 25;39(Pt B):190-198 [PMID: 28579476]
  49. Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19240-5 [PMID: 22084120]
  50. Development. 2015 Apr 1;142(7):1375-86 [PMID: 25804741]
  51. Int J Dev Neurosci. 2008 Nov;26(7):665-71 [PMID: 18768156]
  52. Cell. 2014 Feb 27;156(5):1072-83 [PMID: 24561062]
  53. Sci Rep. 2016 May 05;6:25474 [PMID: 27146274]
  54. Genome Res. 2003 Sep;13(9):2129-41 [PMID: 12952881]

Grants

  1. MR/L023784/1/Medical Research Council
  2. U24 NS078370/NINDS NIH HHS
  3. T32 AG000096/NIA NIH HHS
  4. P30 CA062203/NCI NIH HHS
  5. MR/L023784/2/Medical Research Council
  6. T32 GM087237/NIGMS NIH HHS
  7. P30 ES002109/NIEHS NIH HHS
  8. U54 NS091046/NINDS NIH HHS
  9. R01 NS089076/NINDS NIH HHS

MeSH Term

Adult
Age of Onset
Cell Cycle
Cell Differentiation
Cells, Cultured
Epigenesis, Genetic
Humans
Huntington Disease
Induced Pluripotent Stem Cells
Mitosis
Neostriatum
Neural Stem Cells
Neurons
Transcription Factors
Transcriptome
Up-Regulation
Wnt Signaling Pathway

Chemicals

Transcription Factors